SCHEMBL13232467

SCHEMBL13232467

O=P(OCc1ccccc1)(OCc1ccccc1)Oc1cc(-c2cccc(F)c2)nc2cc3c(cc12)OCO3

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.40
MEN1 O00255 5/20 0.38
KMT2A Q03164 5/20 0.38
NPC1 O15118 2/20 0.38
POLB P06746 1/20 0.38
TP53 P04637 3/20 0.36
DHODH Q02127 2/20 0.36
SMN1; SMN2 Q16637 6/20 0.36
ALDH1A1 P00352 4/20 0.36
MAPK1 P28482 2/20 0.36
LMNA P02545 2/20 0.36
HPGD P15428 4/20 0.36
KDM4E B2RXH2 3/20 0.36
GAA P10253 1/20 0.36
TSHR P16473 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13232475 0.88 ALDH1A1 (0.49) MAPTMEN1KMT2ANPC1SMN1; SMN2
SCHEMBL13232463 0.85 NPC1 (0.36) MAPTMEN1KMT2ANPC1POLB
SCHEMBL8738290 0.85 MEN1 (0.39) MAPTMEN1KMT2ANPC1POLB
SCHEMBL10200098 0.83 ALDH1A1 (0.37) MAPTMEN1KMT2ANPC1POLB
SCHEMBL2798780 0.83 KMT2A (0.45) MAPTMEN1KMT2ANPC1POLB
SCHEMBL15257151 0.82 MAPT (0.42) MAPTMEN1KMT2APOLBDHODH
SCHEMBL13232476 0.81 KDM4E (0.52) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL339857 0.81 KDM4E (0.39) MAPTMEN1KMT2ATP53DHODH
SCHEMBL13232471 0.81 DHODH (0.46) MAPTMEN1KMT2APOLBDHODH
SCHEMBL18294654 0.81 KDM4E (0.40) MAPTMEN1KMT2ANPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9029394-B2 2-phenyl-4-quinolones as anticancer agents CHINA MEDICAL UNIVERSITY (TW) 2015-05-12 US disclosed
US-9023866-B2 2-selenophene-4-quinolones as anticancer agents CHINA MEDICAL UNIVERSITY (TW) 2015-05-05 US disclosed
US-9023867-B2 Hydrophilic derivatives of 2-selenophene-4-quinolones as anticancer agents CHINA MEDICAL UNIVERSITY (TW) 2015-05-05 US disclosed
US-20130253006-A1 2-SELENOPHENE-4-QUINOLONES AS ANTICANCER AGENTS CHINA MEDICAL UNIVERSITY (TW) 2013-09-26 US disclosed
US-20130252999-A1 2-PHENYL-4-QUINOLONES AS ANTICANCER AGENTS CHINA MEDICAL UNIVERSITY (TW) 2013-09-26 US disclosed
US-20130244983-A1 NOVEL HYDROPHILIC DERIVATIVES OF 2-SELENOPHENE-4-QUINOLONES AS ANTICANCER AGENTS CHINA MEDICAL UNIVERSITY (TW) 2013-09-19 US disclosed
US-8440692-B2 Hydrophilic derivatives of 2-aryl-4-quinolones as anticancer agents CHINA MEDICAL UNIVERSITY (TW) 2013-05-14 US disclosed
US-20100168064-A1 NOVEL HYDROPHILIC DERIVATIVES OF 2-ARYL-4-QUINOLONES AS ANTICANCER AGENTS CHINA MEDICAL UNIVERSITY (TW) 2010-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130244983-A1 NOVEL HYDROPHILIC DERIVATIVES OF 2-SELENOPHENE-4-QUINOLONES AS ANTICANCER AGENTS DHX30, SLC20A2, SLC20A1 MAPT 3875/4885MEN1 3325/4885KMT2A 3070/4885
US-20130253006-A1 2-SELENOPHENE-4-QUINOLONES AS ANTICANCER AGENTS DDX5, DHX30, PPIP5K2 MAPT 3672/4885MEN1 2925/4885KMT2A 2349/4885
US-20100168064-A1 NOVEL HYDROPHILIC DERIVATIVES OF 2-ARYL-4-QUINOLONES AS ANTICANCER AGENTS DHX30, SLC20A2, DDX20 MAPT 4187/4885MEN1 3774/4885KMT2A 2887/4885
US-20130252999-A1 2-PHENYL-4-QUINOLONES AS ANTICANCER AGENTS PPIP5K2, DDX5, DHX30 MAPT 3843/4885MEN1 3533/4885KMT2A 2429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.